Pliant Therapeutics

📍 South San Francisco, United States🗓 Founded 2015👥 163 employees💰 Last funded 2018
Biotechnology Research🌐 pliantrx.com
Website LinkedIn
Pliant Therapeutics is a late-stage clinical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases We believe that by harnessing the therapeutic potential of integrin biology and TGF-β modulation, there is a potential to create drug candidates aimed at halting or even reversing fibrotic diseases and address the unmet needs of many patients. Pliant’s co-founders include world-renowned researchers from the University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Pliant Therapeutics?
Pliant Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Pliant Therapeutics last raise funding?
The most recent investment in Pliant Therapeutics recorded on gritt.io was in 2018.
When was Pliant Therapeutics founded?
Pliant Therapeutics was founded in 2015.
What industry is Pliant Therapeutics in?
Pliant Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Pliant Therapeutics based?
Pliant Therapeutics is headquartered in South San Francisco, United States.